Changchun Gaoxin: Leprorelin injection emulsion was approved for drug clinical trial

2022-05-07 0 By

On the evening of March 14th, we announced that our controlling subsidiary Jinsai Pharmaceutical received the approval notice of the clinical trial of Leprorelin injection emulsion from the State Medical Products Administration (SDA).